Connect with us:
CURRENT ISSUE
October 2024
October 2024
Elna Saah, MD, MS
Dr. Saah explores neurodiversity amongst hematology colleagues including the benefits of a neurodiverse team and the need for better inclusion.
October 2024
The majority of patients with iron deficiency did not have resolution of their condition within three years. Among the individuals who did eventually have normal iron stores, resolution of their iron deficiency took almost two years.
October 2024
ASH Clinical News spoke with experts about the diagnosis and treatment of hairy cell leukemia, including the new chemotherapy-free combination option of vemurafenib plus obinutuzumab for newly diagnosed patients.
October 2024
Treatment with teclistamab in patients with relapsed or refractory multiple myeloma who had been previously treated with an anti-B-cell maturation antigen (BCMA) treatment resulted in statistically significant and clinically meaningful responses to the antibody.
